26,863 Views
By Video Games
7,858 Views
By Videobash
2,340 Views
By Videobash
2,461 Views
By Videobash
6,647 Views
By Videobash
11,616 Views
By Videobash
Dwayne “The Rock” Johnson Bio: From the WWF to...
8,115 Views
By watchmojo
Celebrities Pay Tribute to Whitney Houston [HD]
5,503 Views
By SplashNews
Friday Night Lights (2004): Father Bother His Son
857 Views
By AnyClip
Remember Those Screamer Pranks On The Internet?
2,454 Views
By Videobash
5,310 Views
By Videobash
6,142 Views
By Videobash
Kid Does Like 400 Spins Or Something
5,887 Views
By Videobash
Whitney Houston: Retrospective of a Diva [HD]
14,341 Views
By SplashNews
Mario & Sonic at the London 2012 Olympic Games... [HD]
4,677 Views
By CVG
Whitney Houston's Last Appearance? [HD]
14,234 Views
By SplashNews
Race Car Crash, Fire And Escape.
8,950 Views
By Videobash
3,800 Views
By Fox Sports
12 Pack: Kyle Berard [HD]
17,958 Views
By TransWorld
4,554 Views
By SplashNews
04:55
High-Definition
Jess Kimura's Barely EP. 1 [HD]
22,045 Views
By TransWorld
02:37
High-Definition
One Day With Vincent Alvarez [HD]
69,403 Views
By TransWorld
01:33
1,643 Views
By VideoJug
01:49
1,645 Views
By FilmTrailer
00:58
High-Definition
Stars Rock Bright Springtime Colors [HD]
7,723 Views
By SplashNews
03:07
Next Level Pies - Epic Meal Time
29,127 Views
By Revision3
01:55
3,793 Views
By FilmTrailer
00:57
High-Definition
Lourdes' Edgy New Buzz Cut [HD]
7,103 Views
By SplashNews
01:00
High-Definition
Reese Witherspoon's Busting Low Corset [HD]
12,076 Views
By SplashNews
02:46
High-Definition
The Sims 3: Showtime -- Working Your Way Up [HD]
7,615 Views
By Video Games
Add video views to your Facebook Timeline:
The Myelodysplastic Syndromes (MDS) Foundation says data published in the peer reviewed medical journal The Lancet Oncology confirms VIDAZA extends survival for patients with higher-risk MDS. Myelodysplastic syndromes are a group of blood-related malignancies that are difficult to treat and in higher-risk patients have a median survival rate of less than one year. Symptoms include anemia and fatigue, and often patients must rely on blood transfusions to manage the symptoms. VIDAZA, also known by its chemical name, azacitidine, represents a new approach to treatment with important benefits for patients with MDS, and a related condition called acute myeloid leukemia (AML).
To view Multimedia News Release go to http://www.prnewswire.com/mnr/mds-foundation/37124/